How Does Enzyme Finance Work?
Enzyme Finance is one of the oldest on-chain asset management platforms in DeFi, operating since 2017 (originally as Melon Protocol). It enables non-custodial vault creation where managers allocate capital across integrated DeFi protocols with configurable policies and risk controls. With $90M in TVL, 1000+ vaults, and rigorous audit history including PWC audits, its B grade reflects a mature, well-documented design with low mechanism novelty, offset by inherent composability risk from numerous DeFi integrations.
TVL
$89M
Sector
DeFi
Risk Grade
B-
Value Grade
D+
Core Mechanisms
2.3.1
Non-custodial vault system where managers allocate assets across integrated DeFi protocols with configurable policies, fees, and risk controls
Standard vault/fund management pattern. Enzyme has been operating since 2017 (as Melon Protocol) and is one of the earliest on-chain asset management platforms. Over 1000 vaults created.
2.1.2
Management and performance fees charged by vault managers, with protocol fees paid in MLN token
Standard percentage-based fee model. Vault managers set their own fee structures within protocol constraints. Protocol fees are paid in MLN, creating buy pressure.
5.3.1
Enzyme Council governance model with elected council overseeing protocol upgrades and parameter changes
Council-based governance rather than direct token voting. The Enzyme Council manages protocol development and upgrades.
6.4.1
Chainlink and other standard oracle feeds for asset pricing within vaults
Standard oracle dependency for pricing vault assets. Uses industry-standard Chainlink feeds.
1.3.2
MLN buy-and-burn from protocol fee revenue
Protocol fees collected in MLN are partially burned, creating deflationary pressure on MLN supply.
How the Pieces Interact
Vault managers can allocate to any integrated DeFi protocol. An exploit in an integrated protocol (Aave, Compound, Uniswap) would directly impact vaults with positions in that protocol. The composability that enables diverse strategies also propagates external risk.
Each integration adapter and policy contract is a potential attack vector. The modular architecture means that a vulnerability in any single adapter could affect vaults using that integration, though the blast radius is limited to vaults with that specific exposure.
The Enzyme Council controls protocol upgrades, creating centralized decision-making over the infrastructure that holds $90M+ in assets. A compromised council or poor upgrade decision could affect all vaults simultaneously.
As Enzyme expands to Base and other L2s, vault shares may be used as collateral in external DeFi protocols. An exploit affecting vault share pricing could cascade into other protocols that accept Enzyme vault tokens as collateral.
What Could Go Wrong
- Vault managers have discretion over asset allocation within policy constraints. A vault manager could make poor investment decisions or exploit their position within the bounds of their vault's policies, resulting in losses for depositors who rely on the manager's competence.
- Enzyme integrates with numerous external DeFi protocols for vault strategies. Vulnerabilities or exploits in any integrated protocol (Aave, Compound, Uniswap, etc.) could propagate to Enzyme vaults holding positions in those protocols.
- The modular smart contract architecture enables extensive customization of vault policies and integrations. While this provides flexibility, it also increases the attack surface compared to simpler vault designs, as each integration adapter and policy contract represents a potential vulnerability.
- MLN token is used for protocol fees but has limited governance utility. The Enzyme Council controls protocol upgrades, creating a degree of centralization in protocol governance despite the decentralized vault infrastructure.
Cascading DeFi Integration Exploit Propagation
TailTrigger: A critical vulnerability in a major DeFi protocol integrated with Enzyme (e.g., Aave, Compound, or Uniswap) is exploited, draining funds from Enzyme vaults that hold positions in the affected protocol.
- 1.Critical exploit discovered in an integrated DeFi protocol (e.g., Aave lending pool vulnerability) — Attacker drains funds from the exploited protocol, including positions held by Enzyme vaults
- 2.Enzyme vaults with exposure to the exploited protocol lose a portion of their assets — Vault NAV drops sharply; depositors rush to withdraw from affected and unaffected vaults
- 3.Mass withdrawal pressure across Enzyme vaults as depositor confidence drops — Vault managers forced to unwind positions at unfavorable prices to meet redemptions
- 4.MLN token price drops as Enzyme's reputation suffers — Protocol fee revenue declines; MLN burn rate decreases; long-term sustainability questioned
Risk Profile at a Glance
Overall: B- (28/100)
Lower score = safer